Clinical Trial Update: HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HB-adMSCs versus placebo for Juvenile Idiopathic Arthritis has been withdrawn. No results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• HB-adMSCs (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Juvenile Idiopathic Arthritis (JIA) | Phase 2 | Status: WITHDRAWN